Abstract
Our current understanding of clinical significance or the lack thereof of circulating tumor cells (CTCs) is biased by the technology used to isolate these rare cells. Despite the presence of a vast number of academic and commercial technologies, the lack of a standardized and optimized platform has been widely noted. We present a negative enrichment approach, integrating WBC depletion and chemical-free RBC depletion in the same setup without the need for centrifugation, washing or multiple sample handling steps. This approach achieves an average of >90 % recovery of spiked tumor cells and >99 % total WBC depletion in whole blood across multiple cell lines, in a simple and easy-to-use assay. The results presented herein and ongoing improvements aim to fulfill the need for a highly reliable, unbiased, standardized, and optimized CTC isolation platform, using component technologies that are validated for cell isolation.
Similar content being viewed by others
Abbreviations
- CTC:
-
Circulating tumor cells
- WBC:
-
White blood cell
- RBC:
-
Red blood cell
- EMT:
-
Epithelial to mesenchymal transition
- TAC:
-
Tetrameric Antibody Complexes
- GFP:
-
Green florescent protein
- PBS:
-
Phosphate Buffered Saline
- EpCAM:
-
Epithelial cell adhesion molecule
References
W.J. Allard, J. Matera, M.C. Miller, M. Repollet, M.C. Connelly, C. Rao, A.G. Tibbe, J.W. Uhr, L.W. Terstappen, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10(20), 6897–6904 (2004)
P. Balasubramanian, L. Yang, J.C. Lang, K.R. Jatana, D. Schuller, A. Agrawal, M. Zborowski, J.J. Chalmers, Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. Mol. Pharm. 6(5), 1402–1408 (2009)
N. Bednarz-Knoll, C. Alix-Panabières, K. Pantel, Clinical relevance and biology of circulating tumor cells. Breast Cancer Res. 13(20), 228 (2011)
B. Lu, T. Xu, A. Goldkorn, Y.C. Tai, Parylene membrane slot filter for the capture, analysis and culture of viable circulating tumor cells. MEMS 2010: 23rd IEEE International Conference on Micro Electro Mechanical Systems, 935–938 (2010)
G.T. Budd, Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Mol. Pharm. 6(5), 1307–1310 (2009)
J. Chen, J. Li, Y. Sun, Microfluidic approaches for cancer cell detection, characterization, and separation. Lab Chip 12(10), 1753–1767 (2012)
E.H. Cho, M. Wendel, M. Luttgen, C. Yoshioka, D. Marrinucci, D. Lazar, E. Schram, J. Nieva, L. Bazhenova, A. Morgan, A.H. Ko, W.M. Korn, A. Kolatkar, K. Bethel, P. Kuhn, Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 9(1), 16001 (2012)
R.J. Cote, 42nd Annual Oak Ridge Conference, http://www.aacc.org/events/conferences/meeting_proceeding/2010/Documents/RCoteSlides.pdf. Accessed 05 February 2013
M. Cristofanilli, S. Braun, Circulating tumor cells revisited. JAMA 303(11), 1092–1093 (2010)
S. Denis, M. Keith, S. Kam, S. Alison, H. Richard, T. Don, J. Chunsheng, M. Aladin, T. David, D. Yi, C. Jason, W. Michele, P. Bill, C. Walter, A microfluidic system for the selection of circulating tumor cells that utilizes both affinity and size capture technologies. Cancer Res. 72(8), 2389 (2012)
I. Desitter, B.S. Guerrouahen, N. Benali-Furet, J. Wechsler, P.A. Jänne, Y. Kuang, M. Yanagita, L. Wang, J.A. Berkowitz, R.J. Distel, Y.E. Cayre, A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer. Res. 31(2), 427–441 (2011)
Y. Fujiwara, O. Yamazaki, S. Takatsuka, R. Kaizaki, T. Inoue, Granulocyte colony-stimulating factor-producing ascending colon cancer as indicated by histopathological findings: report of a case. Osaka City Med. J. 57(2), 79–84 (2011)
N. Gerges, J. Rak, N. Jabado, New technologies for the detection of circulating tumour cells. Br. Med. Bull. 94, 49–64 (2010)
J.C. Goeminne, T. Guillaume, M. Symann, Pitfalls in the detection of disseminated non-hematological tumor cells. Ann. Oncol. 11(7), 785–792 (2000)
T.M. Gorges, I. Tinhofer, M. Drosch, L. Roese, T.M. Zollner, T. Krahn, O. Ahsen, Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12, 178 (2012)
V. Gupta, I. Jafferji, M. Garza, V.O. Melnikova, D.K. Hasegaw, R. Pethig, D.W. Davis, ApoStream, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics 6(2), 024133 (2012)
J. Hou, K. Matthew, W. Tim, M. Karen, S. Robert, B. Fiona, D. Caroline, Circulating tumor cells, enumeration and beyond. Cancers 2, 1236–1250 (2010)
H.M. Ji, V. Samper, Y. Chen, C.K. Heng, T.M. Lim, L. Yobas, Silicon-based microfilters for whole blood cell separation. Biomed. Microdevices 10(2), 251–257 (2008)
H.J. Kahn, A. Presta, L.Y. Yang, J. Blondal, M. Trudeau, L. Lickley, C. Holloway, D.R. McCready, D. Maclean, A. Marks, Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res. Treat. 86(3), 237–247 (2004)
S. Kasimir-Bauer, O. Hoffmann, D. Wallwiener, R. Kimmig, T. Fehm, Expression of stem cell and epithelial–mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 14(1), 15 (2012)
S.J. Kim, A. Masago, Y. Tamaki, K. Akazawa, F. Tsukamoto, J. Sato, T. Ozawa, Y. Tsujino, S. Noguchi, A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients. Breast Cancer Res. Treat. 128(3), 765–773 (2011)
K.C. Kim, J.H. Yook, J. Eisenbraun, B.S. Kim, R. Huber, Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma—a randomized, controlled pilot study. BMC Complement. Alternat. Med. 12(172) (2012)
O. Lara, X. Tong, M. Zborowski, J.J. Chalmers, Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp. Hematol. 2(10), 891–904 (2004)
L.S. Lim, M. Hu, M.C. Huang, W.C. Cheong, A.T. Gan, X.L. Looi, S.M. Leong, E.S. Koay, M.H. Li, Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells. Lab Chip 12(21), 4388–4396 (2012)
H.K. Lin, S. Zheng, A.J. Williams, M. Balic, S. Groshen, H.I. Scher, M. Fleisher, W. Stadler, R.H. Datar, Y.C. Tai, R.J. Cote, Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16(20), 5011–5018 (2010)
M. Lustberg, K.R. Jatana, M. Zborowski, J.J. Chalmers, Emerging technologies for CTC detection based on depletion of normal cells. Recent Results Cancer Res. 195, 97–110 (2012)
D. Marrinucci, K. Bethel, D. Lazar, J. Fisher, E. Huynh, P. Clark, R. Bruce, J. Nieva, P. Kuhn, Cytomorphology of circulating colorectal tumor cells: a small case series. J. Oncol. (2010). doi:10.1155/2010/861341
S. Meng, D. Tripathy, E.P. Frenkel, S. Shete, E.Z. Naftalis, J.F. Huth, P.D. Beitsch, M. Leitch, S. Hoover, D. Euhus, B. Haley, L. Morrison, T.P. Fleming, D. Herlyn, L.W. Terstappen, T. Fehm, T.F. Tucker, N. Lane, J. Wang, J.W. Uhr, Circulating tumor cells in patients with breast cancer dormancy. Clin. Cancer Res. 10, 8152–8162 (2004)
S. Mocellin, D. Hoon, A. Ambrosi, D. Nitti, C.R. Ross, The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin. Cancer Res. 12(15), 4605–4613 (2006)
K. Pantel, C. Alix-Panabières, S. Riethdorf, Cancer micrometastases. Nat. Rev. Clin. Oncol. 6(6), 339–351 (2009)
J.M. Park, J.Y. Lee, J.G. Lee, H. Jeong, J.M. Oh, Y.J. Kim, D. Park, M.S. Kim, H.J. Lee, J.H. Oh, S.S. Lee, W.Y. Lee, N. Huh, Highly efficient assay of circulating tumor cells by selective sedimentation with a density gradient medium and microfiltration from whole blood. Anal. Chem. 84(17), 7400–7407 (2012)
D.R. Parkinson, N. Dracopoli, B. Gumbs Petty, C. Compton, M. Cristofanilli, A. Deisseroth, D.F. Hayes, G. Kapke, P. Kumar, J.S. Lee, M.C. Liu, R. McCormack, S. Mikulski, L. Nagahara, K. Pantel, S. Pearson-White, E.A. Punnoose, L.T. Roadcap, A.E. Schade, H.I. Scher, C.C. Sigman, G.J. Kelloff, Considerations in the development of circulating tumor cell technology for clinical use. J. Transl. Med. 10, 138 (2012)
P. Paterlini-Brechot, N.L. Benali, Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 253(2), 180–204 (2007)
E. Racila, D. Euhus, A.J. Weiss, C. Rao, J. McConnell, L.W. Terstappen, J.W. Uhr, Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. U. S. A. 95(8), 4589–4594 (1998)
RI Technologies, Circulating tumour cell (CTC) Technologies—An informative market research update from RI technologies, http://www.prweb.com/releases/2012/9/prweb9932999.htm. Accessed 05 February 2013
S. Riethdorf, K. Pantel, Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 75(2), 140–148 (2008)
A. Rolle, R. Günzel, U. Pachmann, B. Willen, K. Höffken, K. Pachmann, Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J. Surg. Oncol. 3(1), 18 (2005)
B.G. Sajay, L. Yuxin, C. Chia-Pin, P.D. Puiu, A.R.A. Rahman, Optimization of breast tumor cells isolation efficiency and purity by membrane filtration. World Academy of Science, Engineering and Technology 69, 801–804 (2012)
J. Selinummi, J. Seppala, O. Yli-Harja, J.A. Puhakka, Software for quantification of labeled bacteria from digital microscope images by automated image analysis. Biotechniques 39(6), 859–863 (2005)
STEMCELL Technologies, Human Whole Blood CD45 Depletion kit protocol, http://www.stemcell.com/~/media/Technical%20Resources/8/3/4/D/E/29037_PIS_1_0_0.ashx. Accessed 05 February 2013
Y.F. Sun, X.R. Yang, J. Zhou, S.J. Qiu, J. Fan, Y. Xu, Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 137(8), 1151–1173 (2011)
S.J. Tan, R.L. Lakshmi, P. Chen, W.T. Lim, L. Yobas, C.T. Lim, Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens. Bioelectron. 26(4), 1701–1705 (2010)
X. Tong, L. Yang, J.C. Lang, M. Zborowski, J. Chalmers, Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytom. B Clin. Cytom. 72(5), 310–323 (2007)
G. Vona, A. Sabile, M. Louha, V. Sitruk, S. Romana, K. Schütze, F. Capron, D. Franco, M. Pazzagli, M. Vekemans, B. Lacour, C. Bréchot, P. Paterlini-Bréchot, Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 156(1), 57–63 (2000)
T. Xu, B. Lu, Y.C. Tai, A. Goldkorn, A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res. 70(16), 6420–6426 (2010)
L. Yang, J.C. Lang, P. Balasubramanian, K.R. Jatana, D. Schuller, A. Agrawal, M. Zborowski, J.J. Chalmers, Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng. 102(2), 521–534 (2009)
M. Yu, S. Stott, M. Toner, S. Maheswaran, D.A. Haber, Circulating tumor cells: approaches to isolation and characterization. J Cell. Biol. 192(3), 373–382 (2011)
X. Zhe, M.L. Cher, R.D. Bonfil, Circulating tumor cells: finding the needle in the haystack. Am. J. Cancer Res. 1(6), 740–751 (2011)
S. Zheng, H.K. Lin, B. Lu, A. Williams, R. Datar, R.J. Cote, Y.C. Tai, 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed. Microdevices 13(1), 203–213 (2011)
L. Zhu, X.L. Peh, H.M. Ji, C.Y. Teo, H.H. Feng, W.T. Liu, Cell loss in integrated microfluidic device. Biomed. Microdevices 9(5), 745–750 (2007)
V. Zieglschmid, C. Hollmann, O. Böcher, Detection of disseminated tumor cells in peripheral blood. Crit. Rev. Clin. Lab. Sci. 42(2), 155–196 (2005)
Acknowledgments
This work was supported by the Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore under the grant number 1031490005. In addition, we greatly appreciate the support from Dr. Chaitanya Kantak for microslit membrane fabrication.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Bhuvanendran Nair Gourikutty Sajay and Chia-Pin Chang contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Sajay, B.N.G., Chang, CP., Ahmad, H. et al. Towards an optimal and unbiased approach for tumor cell isolation. Biomed Microdevices 15, 699–709 (2013). https://doi.org/10.1007/s10544-013-9757-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10544-013-9757-9